Palabras clave
Hospitalización
Inflamación
Obesidad
Cómo citar
Resumen
Objetivo: Evaluar los cambios en el perfil inflamatorio de adultos con obesidad grave (grados II y III) sometidos a tratamiento con una dieta hipocalórica durante la hospitalización.
Método: Estudio de cohorte retrospectivo de naturaleza descriptiva basado en datos de historias clínicas electrónicas de pacientes con obesidad de grados II y III hospitalizados entre 2016 y 2022 en un hospital especializado en el tratamiento de la obesidad.
Resultados: Se observó un predominio de pacientes del sexo femenino, y la mayoría presentaba un comportamiento sedentario. La comparación entre los datos al ingreso y al alta, después de 3 o 6 meses de hospitalización, mostró reducciones significativas en los niveles de proteína C reactiva (PCR), ferritina, peso corporal y porcentaje de grasa corporal (p<0.05).
Conclusiones: Los pacientes hospitalizados para un tratamiento multidisciplinario de la obesidad mostraron reducciones significativas en los marcadores inflamatorios, el peso corporal y la adiposidad. Aunque los niveles de PCR y ferritina disminuyeron de manera similar en los pacientes hospitalizados durante 3 o 6 meses, el período de hospitalización de 6 meses fue más efectivo para reducir el peso corporal y la adiposidad.
Citas
ABESO (Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica), Departamento de Nutrição. Posicionamento sobre o tratamento nutricional do sobrepeso e da obesidade. 2022. Disponível em: https://abeso.org.br/wp-content/uploads/2022/11/posicionamento_ 2022-alterado-nov-22-1.pdf Acesso em: 30 de outubro de 2024.
BIANCHI, V.E. Weight loss is a critical factor to reduce inflammation. Clinical nutrition ESPEN, v.28, p.21-35, 2018.
BUCHOWSKI, M. S.; HONGU, N.; ACRA, S.; WANG, L.; WAROLIN, J.; ROBERTS, L. J. 2nd. Effect of modest caloric restriction on oxidative stress in women, a randomized trial. PLoS One, v. 7, n. 10, p. e47079, 2012.
CAMHI, S.M.; STEFANICK, M.L.; RIDKER, P.M.; YOUNG, D.R. Changes in C-reactive protein from low-fat diet and/or physical activity in men and women with and without metabolic syndrome. Metabolism: Clinical and Experimental, v.59, n.1, p.54-61, 2010.
HO, A.K.; BARTELS, C.M.; THORPE, C.T.; PANDHI, N.; SMITH, M.A.; JOHNSON, H.M. Achieving weight loss and hypertension control among obese adults: a US multidisciplinary group practice observational study. American Journal of Hypertension, v.29, n.8, p.984-991, 2016.
ION, R. M.; SIBIANU, M.; HUTANU, A.; BERESESCU, F. G.; SALA, D. T.; FLAVIUS, M.; NEAGOE, R. M. A comprehensive summary of the current understanding of the relationship between severe obesity, metabolic syndrome, and inflammatory status. Journal of Clinical Medicine, v. 12, n. 11, p. 3818, 2023.
IZAOLA, O.; LUIS, D.; SAJOUX, I. ; DOMINGO, J.C. ; VIDAL, M. Inflamación y obesidad (lipoinflamación). Nutricion Hospitalaria, v. 31, n. 6, p. 2352-2358, 2015.
KHAN, A.; KHAN, W.M.; AYUB, M.; HUMAYUN, M.; HAROON, M. Ferritin is a marker of inflammation rather than iron deficiency in overweight and obese people. Journal of obesity, v.2016, n.1, p.1937320, 2016.
KWAIFA, I. K.; BAHARI, H.; YONG, Y. K.; NOOR, S. M. Endothelial dysfunction in obesity-induced inflammation: molecular mechanisms and clinical implications. Biomolecules, v. 10, n.2, p.291, 2020.
KEMALASARI, I.; FITRI, N.A.; SINTO, R.; TAHAPARY, D.L.; HARBUWONO, D.S. Effect of calorie restriction diet on levels of C reactive protein (CRP) in obesity: A systematic review and meta-analysis of randomized controlled trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, v.16, n.3, p.102388, 2022.
MACEDO, A.V.S. Tratamento Direcionado ao Sistema Renina-Angiotensina-Aldosterona na Obesidade. Arquivos Brasileiros de Cardiologia, v.115, p.29-30, 2020.
NAZMI, A.; OLIVEIRA, I.O; VICTORA, C.G. Correlates of C-reactive protein levels in young adults: a population-based cohort study of 3827 subjects in Brazil. Brazilian Journal of Medical and Biological Research, v.41, p.357-367, 2008.
ORGANIZAÇÃO MUNDIAL DA SAÚDE. Obesity: preventing and managing the global epidemic of obesity. Geneva: OMS. Report of the WHO consultation. World Health Organ Tech Rep Ser. 2000; 894:i-xii, 1-253.
ORGANIZAÇÃO MUNDIAL DA SAÚDE. Obesity and overweight. Geneva: OMS, 2024. Report of the who consultation of obesity. Disponível em: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight Acesso em: 30 de outubro de 2024.
RAHIMI, G.R.; YOUSEFABADI, H.A.; NIYAZI, A.; RAHIMI, N.M.; ALIKHAJEH, Y. Effects of lifestyle intervention on inflammatory markers and waist circumference in overweight/obese adults with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Biological Research for Nursing, v.24, n.1, p,94-105, 2022.
REES, M.; COLLINS, C.E.; VLIEGER, N.D.; McDONALD, V.M. Non-surgical interventions for hospitalized adults with class II or class III obesity: a scoping review. Diabetes, Metabolic Syndrome and Obesity, v.14, p.417-429, 2021.
RYAN, B. J.; VAN PELT, D.W.; GUTH, L.M.; LUDZKI, A.C.; GIOSCIA-RYAN, R.A.; AHN, C.; FOUG, K.L.; HOROWITZ, J.F. Plasma ferritin concentration is positively associated with in vivo fatty acid mobilization and insulin resistance in obese women. Experimental Physiology, v.103, n.11, p.1443-1447, 2018.
STECKHAN, N.; HOHMANN, C. D.; KESSLER, C.; DOBOS, G.; MICHALSEN, A.; CRAMER, H. Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: A systematic review and meta-analysis. Nutrition, v.32, n.3, p.338-348, 2016.
SUÁREZ-ORTEGÓN, M.F.; ENSALDO-CARRASCO, E.; SHI, T.; MCLACHLAN, S.; FERNÁNDEZ-REAL, J.M.; WILD, S.H. Ferritin, metabolic syndrome and its components: A systematic review and meta-analysis. Atherosclerosis, v.275, p.97-106, 2018.
TAYLOR, E. B . The complex role of adipokines in obesity, inflammation, and autoimmunity. Clinical Science, v.135, n.6, p.731-752, 2021.
TENG, I.C.; TSENG, S.H.; AULIA, B.; SHIH, C.K.; BAI, C.H.; CHANG, J.S. Can diet‐induced weight loss improve iron homoeostasis in patients with obesity: A systematic review and meta‐analysis. Obesity Reviews, v.21, n.12, p.e13080, 2020.
UUSITUPA, M.; HERMANSEN, K.; SAVOLAINEN, M. J.; SCHWAB, U.; KOLEHMAINEN, M.; BRADER, L.; et al. Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome - a randomized study (SYSDIET). Journal of Internal Medicine, v.274, n.1, p.52-66, 2013.
WILLIAMS, B. et al. 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. In: Manual of Hypertension of the European Society of Hypertension, Third Edition. CRC Press, 2019. p. 543-627.
YOO, K.D.; KO, S.H.; PARK, J.E.; AHN, Y.B.; YIM, H.W.; LEE, W.C.; PARK, Y.M. High serum ferritin levels are associated with metabolic risk factors in non‐obese Korean young adults: Korean National Health and Nutrition Examination Survey (KNHANES) IV. Clinical endocrinology, v.77, n.2, p.233-240, 2012.
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Derechos de autor 2024 Ana Pimenta, Sérgio Q. Braga, Domingos L. S. Rios, Marcia Almeida